Oxygenta Pharmaceutical Ltd - Announcement under Regulation 30 (LODR)-Allotment

We wish to inform you that, the Board of Directors of Oxygenta Pharmaceutical Limited (formerly known as S.S. Organics Ltd.) at its meeting held on 29th April, 2023, has approved the conversion of warrants into Equity shares pursuant to exercise of option attached to convertible warrants by the warrant holders & accordingly allotted 85,80,700 (Eighty-Five Lakhs Eighty Thousand and Seven hundred) fully paid-up Equity shares of a face value of Rs. 10/- each to the following warrant holders, under Promoter and Non-Promoter category at a price of Rs. 15/- (Rupees Fifteen only) per Equity share, being the price not less than the price determined in accordance with the Chapter V of SEBI (ICDR) Regulations, 2018. Kindly take the above information on record and acknowledge. Thanking you